Puberty Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about Puberty clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Data Collection Study of Pediatric and Adolescent Gynecology Conditions

Disorders of Sex Development (DSD)Pediatric and Adolescent Cancers of the Genital TractReproductive Endocrine Conditions in Puberty+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)11,000 enrolled1 locationNCT04717349
Recruiting
Not Applicable

ActiveGirls: Physical Activity, Hormone Health, and Diabetes Risk in Early Adolescence

Insulin ResistancePhysical ActivityPCOS (Polycystic Ovary Syndrome)+1 more
Massachusetts General Hospital40 enrolled1 locationNCT07102797
Recruiting
Early Phase 1

Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

PubertyHyperandrogenism
University of Virginia36 enrolled1 locationNCT00929006
Recruiting
Early Phase 1

Hyperandrogenemia and Altered Day-night LH Pulse Patterns

Polycystic Ovary SyndromePubertyHyperandrogenism
University of Virginia32 enrolled1 locationNCT03068910
Recruiting
Early Phase 1

Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?

Polycystic Ovary SyndromePubertyHyperandrogenism
University of Virginia32 enrolled1 locationNCT04723862
Recruiting

Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)

PubertyType 2 Diabetes MellitusDiabetic Kidney Disease+3 more
Petter Bjornstad100 enrolled2 locationsNCT05008276
Recruiting

Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate

Kallmann SyndromeHypogonadotropic HypogonadismHypothalamic Amenorrhea+5 more
Centre Hospitalier Universitaire Vaudois2,000 enrolled1 locationNCT01601171